Quince Therapeutics, Inc. ( QNCX) - Stock Earnings
QNCX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -39.5 million USD | — USD |
| 2026Q1 | 35.9 million USD | — USD |
| 2026Q2 | -75.5 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
QNCX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -31.4 million USD | — USD |
| 2024 | -56.8 million USD | — USD |
| 2025 | -84.0 million USD | — USD |
| 2026 Est. | — | — |
QNCX
Price: $33.93
52 week price:
Earnings Per Share: -210.00 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 34.7 million